|

Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)

RECRUITINGN/ASponsored by Boston Medical Center
Actively Recruiting
PhaseN/A
SponsorBoston Medical Center
Started2025-01-06
Est. completion2026-03
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
Locations1 site

Summary

This project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been adapted to better fit the experiences and unique issues of those that have been hospitalized with serious injection related infections (SIRI) based on the findings from a prior qualitative study from the principal investigator. This project plans to test the adapted intervention within a smaller group of participants to assess feasibility, acceptability, and calculate early findings of intervention efficacy. Hospitalizations for SIRIs are a unique entry point for patients to start their recovery journey with medications for OUD (MOUD), but many people do not remain on long-term treatment, despite evidence that indicates MOUDs reduce death and re-hospitalization after SIRIs. The study objectives are to: * Assess the implementation feasibility of the adapted RMC model for patients with SIRI and OUD. * Establish preliminary estimates of intervention efficacy. * Make further adaptions to the intervention that will reduce both known and unknown barriers to care and increase effectiveness in future larger scale trials. Findings from this pilot study will result in further intervention refinement to better fit the target population, and serve as the basis for a larger randomized control trial that will have aims focused on more in-depth analysis of the efficacy of this program

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Between 18 and 65 years of age
* Able to provide Informed Consent
* Admitted to Boston Medical Center on any inpatient unit for an active serious injection related infection (SIRI) such as endocarditis, osteomyelitis, bacteremia, septic arthritis, epidural abscess or other serious infection in which two weeks or more of antibiotics are recommended

Exclusion Criteria:

* Not able to give informed consent
* Cognitive ability (defined through Research Assistant (RA) determination)
* Inability to complete assessments in English or Spanish (defined through RA determination).
* Exclusion for any reason under PI discretion
* Unable to provide names and contact information for at least two verifiable locator persons who will know where to find them in the future.
* In police custody or expecting incarceration

Conditions8

ArthritisBloodstream InfectionEndocarditisEpidural AbscessHeart DiseaseOpioid Use DisorderOsteomyelitisSeptic Arthritis

Locations1 site

Boston Medical Center
Boston, Massachusetts, 02118
Simeon Kimmel, MD857-292-6484Simeon.Kimmel@bmc.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.